Related Experiment Video
Updated: Apr 19, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Plasma glutamine deficiency is associated with multiple organ failure in critically ill children
Leif Ekmark1, Olav Rooyackers, Jan Wernerman
1Department of Pediatric Anaesthesia and Intensive Care, Astrid Lindgren Children's Hospital, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Insights
Low plasma glutamine levels in critically ill children admitted to the pediatric intensive care unit (PICU) are linked to multiple organ failure. Glutamine levels often normalize within five days for children who survive.
Area of Science:
- Pediatric critical care medicine
- Clinical nutrition
- Biochemistry
Background:
- Low plasma glutamine is a risk factor for mortality in adult critical care.
- Glutamine metabolism in critically ill children is not well understood.
- Pediatric intensive care unit (PICU) mortality is low, making it difficult to use as an endpoint.
Purpose of the Study:
- To investigate the relationship between plasma glutamine concentration at PICU admission and the development of multiple organ failure in children.
- To utilize the pediatric logistic organ dysfunction (PELOD) score to assess organ failure.
Main Methods:
- Observational study including 149 critically ill children and 60 healthy controls.
- Plasma glutamine concentration and PELOD score measured at PICU admission.
- Measurements repeated on day 5 for patients still in the PICU.
Main Results:
- PICU patients had significantly lower plasma glutamine concentrations than controls.
- Low plasma glutamine at admission was associated with increased organ failure (PELOD score).
- Plasma glutamine normalized within 5 days in most surviving critically ill children.
Conclusions:
- Initial plasma glutamine deficiency in critically ill children is associated with multiple organ failure.
- The normalization pattern of plasma glutamine in children differs from that in adults.
- Plasma glutamine levels may serve as an early indicator of organ dysfunction in pediatric critical care.
Abstract:
A low plasma glutamine concentration (<420 µmol/L) is an independent risk factor for mortality in critically ill adult patients. Glutamine metabolism in children is less well characterized. However, pediatric ICU (PICU) mortality is low and, therefore, mortality is difficult to use as an endpoint. Here we evaluated if plasma glutamine concentration at admission to the PICU, relates to the development of multiple organ failure, using pediatric logistic organ dysfunction score (PELOD)-score. In this observational study, consecutive critically ill children (n = 149) admitted to the PICU of a tertiary university hospital as well as a reference group of healthy children (n = 60) were included. Plasma glutamine concentration and the PELOD were determined at admission for all patients and at day 5 for those patients still in the PICU. Plasma glutamine concentration at admission was low in the PICU patients as compared to controls (p = 0.00002) and patients with a low plasma glutamine concentration had more organ failure as compared to patients with higher plasma glutamine concentration (p = 0.0001). Plasma glutamine concentration normalized in patients staying >5 days in the PICU. Plasma glutamine depletion was present in 40 % of patients at PICU admission and it was associated with the development of multiple organ failure. Furthermore, the majority of the critically ill children normalized their plasma glutamine concentration within 5 days, which is different from adult ICU patients. The study suggests that an initial plasma glutamine deficiency is associated with multiple organ failure in critically ill children.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Excretion

